Oakleaf Care (Hartwell) Limited has been acquired by CareTech Holdings Plc
March 2016 — The private shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) have sold the company to CareTech Holdings Plc (CareTech) for an undisclosed consideration.
Oakleaf Care provides brain injury rehabilitation to adult males requiring specialist care and long-term support. Based in Northamptonshire, UK, the group operates over 80 beds across a number of sites, with highly trained staff providing a seamless rehabilitation pathway of care for men with acquired brain injury (ABI). The business continues to expand, with a new 22-bed care home opening this quarter bringing the total to over 100 beds.
CareTech is a provider of specialist social care services in the UK, supporting adults and children with a wide range of complex needs across more than 250 specialist services. This acquisition gives CareTech a presence in ABI rehabilitation, enabling it to offer additional pathways to its client care group.
Our role in the transaction
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more